Seth Quillin squillin

OMG! Trending and futuring runs in the family

girls

I recently had the pleasure of taking two of my teenage daughters to the local cellphone store to have their phones repaired or replaced (evidently these devices need replaced often when you average 8,000 text a month).  But this 60-minute shopping experience was preview, a reminder, for me about how our lab needs to not only identify the latest trends but potentially begin to model future trends and opportunities based on emerging consumer expectations and behaviors.

Read Full Entry

squillin

Content is still the currency

twitter newspaper cover

We’ve all seen the headlines about the state of the newspaper industry: falling revenues, fleeing subscribers, a failing model. But even as these legacy outlets struggle, they’re still our go-to source for compelling, credible content.

Legacy news brands are winning on latest technology

The New York Times has become the first major newspaper to have more Twitter followers than print subscribers (2,668,948 vs 951,000). Wired for iPad has sold an average of 30,000 copies per month (after its blockbuster premiere issue) at the premium price of $4.99 an issue. That number is already about 37% of the magazine’s newsstand sales.

Read Full Entry

squillin

See you at Next Gen next week?

NextGen

We learned a ton about how to better connect with ePatients and the new generation of engaged healthcare providers at Kru Research’s ePatient Conference in September. Now, we’re headed out to the Next Gen Pharma conference in Baltimore to get fresh perspectives from pharma executives and sales leaders themselves – what are their pain points, their big new ideas, their break-out strategies for making one-on-one connections with providers and payors?

The conference kicks off in Baltimore next Tuesday and runs through Wednesday night. You can find us three places there:

  1. At our mobile lab: As a conference sponsor, we’ve got a little room on the floor – so, we’re bringing some of our latest models and innovation ideas to share. Come play with a new gadget, check out a prototype and give us your feedback on what you’d like to see taken to the next level. Read Full Entry
squillin

Live blogging: ePatient 2010 – shorts & briefs

Live-Blogging

Sleep, Zeo and the Quantified Self
Ben Rubin, Zeo

  • Ben, the co-founder of Zeo Inc, was here to showoff their personal biometric tool for measuring sleep.
  • Emerging trend in wellness: More powerful sensors for ePatients
  • Sleep is a societal issue that doesn’t get the weight that it should. There are 100 million poor sleepers in the US. It’s the #2 health complaint of 65+
  • Zeo gives you a ZQ (your personal sleep score) + recommendations on what to try to get better sleep

The Yellow Brick Road: The Patient’s Path to Empowerment
Jeanne Barnett, Medrise CysticFibrosis.com

  • The diagnosis is like a tornado, spinning ePatients out of everything they know
  • “I’d say welcome, but this is not a place parents should hope to go”
  • ePatients often say “because of this site, now I know what my doctor is talking about”
  • This community is risk engaged, not risk adverse

Read Full Entry

squillin

Live blogging: ePatient 2010 – e-Patients & Clinical Trials

Live-Blogging

Case Study: Safety, Surveys & Recruitment: Why 2 Million+ People Engage with iGuard
Dr. Hugo Stephenson, iGuard

  • iGuard.org was created by Quintiles – one of the biggest clinical research companies in the world
    • Goal in creating it was both improving safety and building a community of patients for clinical research
  • iGuard is the largest medication monitoring service and largest patient-centric research platform in the world
    • 2.4 million members today
    • For example: 152,140 patients with migraines; 20,090 epilepsy; 212,190, depression; 169,452, diabetes; 9877, MS
  • Tried 60+ methods to seed community participation
    • What worked: lots of value + light touch
    • “If we want to create a pool of patients for research, we have to offer them something first” – do something good for patients: Free medication checks + rapid safety alerts + access to feedback from thousands of patients
  • Today, iGuard has registries for hundreds of products
    • 11-25% of patients iGuard reaches out to for research activity respond within 24 hours
    • 97% retention after 18 months

Read Full Entry

squillin



Bad Behavior has blocked 1325 access attempts in the last 7 days.